|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| Myelodysplastic Syndromes | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Preleukemia | |||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Bone Marrow Diseases | |||||
| Disease | |||||
| Hematologic Diseases | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Pathologic Processes | |||||
| Precancerous Conditions | |||||
| 4 | Interventions listed in this trial | ||||
| ras peptide cancer vaccine | |||||
| sargramostim | |||||
| 5 | Sponsors listed in this trial | ||||
| Memorial Sloan-Kettering Cancer Center | |||||
| National Cancer Institute (NCI) | |||||